China Contract Research Organization (CRO) Industry Research

　　Chinese CRO market that kicked off much later than the United States and Europe is growing much faster. The outsourced clinical testing industry in China grew at a CAGR of 27.2% from 2007 to 2013 to reach CNY36 billion (USD5.9 billion) in 2013, and makes up approximately 10% of the global market. And while a slew of foreign CROs have piled into China, the country is now also home to some 500 homegrown players.
　　According to the National Bureau of Statistics of China and Ministry of Health of China, the data of China Contract Research Organization (CRO) Industry Research Report is authoritative.

Chapter 1 China CRO Industry Introduction
　　1.1 Contract Research Organization (CRO) Definition
　　1.2 About the Industry
　　　　1.2.1 Classification
　　　　1.2.2 Features
　　　　1.2.3 Meaning
　　1.3 Industry at a Glance
　　　　1.3.1 Background
　　　　1.3.2 Development History
　　　　1.3.3 Key Factors
Chapter 2 External Drivers of China CRO Industry
　　2.1 Policy
　　　　2.1.1 Official regulation
　　　　2.1.2 National guidelines
　　　　2.1.3 National standards
　　2.2 Economy
　　　　2.2.1 Worldwide economy behavior
　　　　2.2.2 China economic growth
　　　　2.2.3 Development Trends
　　2.3 Society
　　　　2.3.1 Population
　　　　2.3.2 Income
　　　　2.3.3 Drug awareness
Chapter 3 China CRO Industry Performance
　　3.1 Global CRO Industry Development Overview
　　　　3.1.1 Executive Summary
　　　　3.1.2 Market Entity
　　　　3.1.3 Market Structure
　　　　3.1.4 Scale Analysis
　　3.2 China CRO Industry Development Overview
　　　　3.2.1 Executive Summary
　　　　3.2.2 Market Entity
　　　　3.2.3 Market Structure
　　　　3.2.4 Industry feature
　　3.3 China CRO Industry Current Performance
　　　　3.3.1 Economy Scale
　　　　3.3.2 Influencing factors
　　　　3.3.3 Market special features
　　　　3.3.4 Strong Points
　　　　3.3.5 Weak Pointes
Chapter 4 China CRO Industry Regional Development
　　4.1 Beijing
　　　　4.1.1 Situation
　　　　4.1.2 Scale
　　　　4.1.3 Advantage
　　　　4.1.4 Trends
　　4.2 Shanghai
　　　　4.2.1 Situation
　　　　4.2.2 Scale
　　　　4.2.3 Advantage
　　　　4.2.4 Trends
　　4.3 Nanjing
　　　　4.3.1 Situation
　　　　4.3.2 Scale
　　　　4.3.3 Advantage
　　　　4.3.4 Trends
　　4.4 Tianjin
　　　　4.4.1 Situation
　　　　4.4.2 Scale
　　　　4.4.3 Advantage
　　　　4.4.4 Trends
Chapter 5 Major Companies of China CRO Industry
　　5.1 China CRO Industry Major Companies list
　　5.2 Wuxi AppTec
　　　　5.2.1 Introduction
　　　　5.2.2 Development history
　　　　5.2.3 Market Position
　　　　5.2.4 Financial Performance
　　　　5.2.5 Projects
　　　　5.2.6 Prospects
　　5.3 ShangPharma Corp
　　　　5.3.1 Introduction
　　　　5.3.2 Development history
　　　　5.3.3 Market Position
　　　　5.3.4 Financial Performance
　　　　5.3.5 Projects
　　　　5.3.6 Prospects
　　5.4 Other Players in China
　　　　5.4.1 Shanghai Mediclon Inc.
　　　　5.4.2 Sundia MediTech Company Ltd.
　　　　5.4.3 Guangzhou Yushi Medicinal Technology Co., Ltd.
　　　　5.4.4 Guangzhou Boji Medical Biotechnological Co., Ltd.
Chapter 6 China CRO Industry Investing Analysis
　　6.1 China CRO Industry Investing Situation
　　　　6.1.1 Barriers to entry
　　　　6.1.2 Capital intensity
　　　　6.1.3 Capital entry scale
　　　　6.1.4 Foreign capital entry
　　6.2 China CRO Industry Investment Risks
　　　　6.2.1 Interest rate risk
　　　　6.2.2 Business risk
　　　　6.2.3 Market risk
　　　　6.2.4 Reinvestment risk
　　6.3 Investment Opportunities
　　　　6.3.1 Trade promotion opportunities
　　　　6.3.2 Products options
　　　　6.3.3 Foreign entity
Chapter 7 China CRO Industry Trends and Prospect Analysis from CIConsulting
　　7.1 China CRO Industry Development Trends
　　　　7.1.1 Industry trends
　　　　7.1.2 Market trends
　　7.2 China CRO Industry Outlook
　　　　7.2.1 Downstream Demand
　　　　7.2.2 Globalization
　　　　7.2.3 Competition
　　　　7.2.4 Technology
　　7.3 CIConsulting Prediction for China CRO Industry , 2015-2019
　　　　7.3.1 Scale
　　　　7.3.2 Revenue
　　　　7.3.3 Profit